Arsenal Biosciences, Inc.

📍 South San Francisco, United States🗓 Founded 2019👥 173 employees💰 Last funded Jul 2026
Biotechnology Research🌐 arsenalbio.com
Website LinkedIn
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2019
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
United Kingdom
1
Investor activity2020–2026 · investors recorded per year
202012024120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arsenal Biosciences, Inc.?
Arsenal Biosciences, Inc. has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Arsenal Biosciences, Inc. last raise funding?
The most recent investment in Arsenal Biosciences, Inc. recorded on gritt.io was in July 2026.
When was Arsenal Biosciences, Inc. founded?
Arsenal Biosciences, Inc. was founded in 2019.
What industry is Arsenal Biosciences, Inc. in?
Arsenal Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arsenal Biosciences, Inc. based?
Arsenal Biosciences, Inc. is headquartered in South San Francisco, United States.